TriVentures is an early-stage venture capital firm that invests in innovative companies converging technology and healthcare to solve critical industry challenges. Their strategy focuses on data-driven healthcare, tech-health convergence, disruptive medical devices, and bio-convergence, aiming to create a healthier future through data-driven solutions and cross-industry convergence.
75% of their portfolio is in Healthcare. Average disclosed round size is $31.9M (across 8 rounds with reported amounts).
Portfolio
8
Fund Size
$200M
Top Stage
Seed
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Cala Health | Growth | $50M | Dec 2024 |
 Monogoto | Series A | $27M | Oct 2024 |
 FeelBetter | Seed | $5.9M | Jul 2023 |
 FEMSelect | Series B | $9M | Oct 2022 |
| FFuture Family | Series B | $25M | Apr 2022 |
 Medisafe | Series C | $30M | Feb 2021 |
 V-Wave Ltd. | Series C | $98M | Sep 2020 |
 GRIN | Seed | $10M | — |
Top Co-Investors
OurCrowd2 shared
Deerfield1 shared
Aperture Venture Partners1 shared
Endeavour Vision1 shared
Pontifax1 shared
Pura Vida Investments1 shared
Munich Re Ventures1 shared
MS&AD Ventures1 shared
Mindset Venture1 shared
Lux Capital1 shared
GV (Google Ventures)1 shared
Vertex Growth Fund1 shared
Nexus NeuroTech Ventures1 shared
Action Potential Venture Capital1 shared
Lightstone Ventures1 shared
Ascension Ventures1 shared
Peak6 Strategic Capital1 shared
Octopus Ventures1 shared
Sanofi Ventures1 shared
Alive Israel HealthTech Fund1 shared
Last updated: 16 April 2026